Aptose Biosciences Inc. - ROE
APTO
Price:
$1.71
Market Cap:
$4.36M
Aptose Biosciences Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to discovering and advancing personalized therapeutic solutions to address critical unmet medical needs within the field of oncology, primarily focusing on the United States market. Its active clinical pipeline features several promising candidates. APTO-253 is currently undergoing Phase 1a/b clinical evaluation for patients battling relapsed or treatment-resistant blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS). Another compound, HM43239, is progressing through Phase 1/2 clinical trials, specifically targeting individuals with relapsed or refract...[Read more]
Industry
Biotechnology
IPO Date
1992-03-16
Stock Exchange
NASDAQ
Ticker
APTO
PE Ratio
[-0.05]
ROE
[-23.18%]
Current Ratio
[0.55]
Dividend Yield
[0%]
Enterprise Value
[3.42M]
Dividend History
The ROE as of June 2026 (TTM) for Aptose Biosciences Inc. (APTO) is -23.18%
According to Aptose Biosciences Inc.’s latest financial reports and current stock price. The company's current ROE is -23.18%. This represents a change of -3559.19% compared to the average of 0.67% of the last 4 quarters.
Aptose Biosciences Inc. (APTO) Historical ROE (quarterly & annually)
How has APTO ROE performed in the past?
The mean historical ROE of Aptose Biosciences Inc. over the last ten years is 154.32%. The current -23.18% ROE has changed -115.02% with respect to the historical average. Over the past ten years (40 quarters), APTO's ROE was at its highest in in the December 2023 quarter at 412.10%. The ROE was at its lowest in in the March 2024 quarter at -7036.50%.
Average
154.32%
Median
-67.24%
Minimum
-205.01%
Maximum
1.77%
Aptose Biosciences Inc. (APTO) ROE by Quarter and Year
Discovering the peaks and valleys of Aptose Biosciences Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 144.94%
Maximum Annual ROE = 1.77%
Minimum Annual Increase = -1692.87%
Minimum Annual ROE = -205.01%
| Year | ROE | Change |
|---|---|---|
| 2025 | 0% | -100.00% |
| 2024 | 559.76% | -68.29% |
| 2023 | 1.77% | -1692.87% |
| 2022 | -110.82% | 25.88% |
| 2021 | -88.04% | 89.52% |
| 2020 | -46.45% | 66.04% |
| 2019 | -27.98% | -86.35% |
| 2018 | -205.01% | 79.36% |
| 2017 | -114.30% | -39.56% |
| 2016 | -189.11% | 144.94% |
Aptose Biosciences Inc. (APTO) Average ROE
How has APTO ROE performed in the past?
The current ROE of Aptose Biosciences Inc. (APTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
774.97%
5-year avg
425.21%
10-year avg
154.32%
Aptose Biosciences Inc. (APTO) ROE vs. Peers
How is APTO’s ROE compared to its peers?
Aptose Biosciences Inc.’s ROE is less than Gamida Cell Ltd. (1.15%), greater than Rubius Therapeutics, Inc. (-238.11%), greater than Idera Pharmaceuticals, Inc. (-113.18%), greater than Nabriva Therapeutics plc (-201.91%), greater than Atreca, Inc. (-83.28%), greater than Gritstone bio, Inc. (-124.41%), greater than Aravive, Inc. (-306.06%), greater than RVL Pharmaceuticals plc (-80.88%), greater than Oncorus, Inc. (-82.19%), greater than Affimed N.V. (-100.55%),
| Company | ROE | Market cap |
|---|---|---|
| 1.15% | $4.34M | |
| -238.11% | $0 | |
| -113.18% | $0 | |
| -201.91% | $323.00 | |
| -83.28% | $3.57M | |
| -124.41% | $3.80M | |
| -306.06% | $2.95M | |
| -80.88% | $3.14M | |
| -82.19% | $0 | |
| -100.55% | $2.98M |
Build a custom stock screener for Aptose Biosciences Inc. (APTO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptose Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Aptose Biosciences Inc. (APTO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Aptose Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Aptose Biosciences Inc.'s ROE?
How is the ROE calculated for Aptose Biosciences Inc. (APTO)?
What is the highest ROE for Aptose Biosciences Inc. (APTO)?
What is the 3-year average ROE for Aptose Biosciences Inc. (APTO)?
What is the 5-year average ROE for Aptose Biosciences Inc. (APTO)?
How does the current ROE for Aptose Biosciences Inc. (APTO) compare to its historical average?